Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Cost of Revenue: 2020-2022

Historic Cost of Revenue for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to $158,122.

  • Immuneering's Cost of Revenue fell 91.17% to $19,343 in Q3 2022 from the same period last year, while for Sep 2022 it was $364,343, marking a year-over-year decrease of 74.34%. This contributed to the annual value of $158,122 for FY2022, which is 86.29% down from last year.
  • According to the latest figures from FY2022, Immuneering's Cost of Revenue is $158,122, which was down 86.29% from $1.2 million recorded in FY2021.
  • Immuneering's 5-year Cost of Revenue high stood at $1.3 million for FY2020, and its period low was $158,122 during FY2022.
  • In the last 3 years, Immuneering's Cost of Revenue had a median value of $1.2 million in 2021 and averaged $863,840.
  • Data for Immuneering's Cost of Revenue shows a maximum YoY crashed of 86.29% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Immuneering's Cost of Revenue stood at $1.3 million in 2020, then declined by 9.94% to $1.2 million in 2021, then slumped by 86.29% to $158,122 in 2022.